Nanoparticles as experimental prostate cancer treatment

Numéro d’image : 12638797
Nanoparticles as experimental prostate cancer treatment
Nanoparticles as experimental prostate cancer treatment. Medical imaging of prostate cancer cells (centre) and mouse models used to develop nanoparticles to treat the cancer. A protein called Prostate Specific Membrane Antigen (PSMA-1) is highly expressed by prostate cancer cells. Here, gold nanoparticles targeted to PSMA-1 selectively deliver an imaging agent and a drug called Pc4 (red, centre) to PSMA-expressing cells (blue, centre). In mice, the nanoparticles are targeted to the tumour (right, nanoparticles in red) but not healthy tissue (left). The goal of this nanotechnology is to provide surgical guidance for prostate cancer surgery, and therapeutic intervention when surgery is insufficient. This is part of an approach known as theranostics. This image was created in 2016, as part of research carried out at Case Western Reserve University, USA.
Licence : Droits gérés
Crédit: Science Photo Library / Case Western Reserve University / NATIONAL CANCER INSTITUTE
Taille de l’image : 6000 px × 3000 px
Model Release : Non requis
Property Release : Non requis
Restrictions : -

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;